It was on this day six years ago that we learned the T-cell therapy had not only saved Emily's life, but also left no evidence of leukemia cells. She was free of cancer, and Kari and I didn’t have to find out what it would be like living without our only daughter.
For the third year in a row, the Emily Whitehead Foundation participated in the Pittsburgh Marathon as an official charity partner. While the fundraising window remains open until May 31, our team has so far raised over $12,000!
Today is Emily's 13th birthday! It is incredibly special to us that this year Emily's birthday coincides with yet another advancement of the CAR-T cell therapy that saved her life.
Dr. Carl June Named One of TIME’s 100 Most Influential People of 2018—Emily Whitehead Writes Tribute
Dr. Carl June, Penn Medicine, has been named one of TIME Magazine's 100 most influential people in the world. As a surprise to Dr. June, Emily Whitehead was asked to write a brief tribute for the 2018 TIME 100 issue.
On Tuesday, April 17, the Emily Whitehead Foundation presented Children's Hospital of Philadelphia (CHOP)'s Dr. Stephan A. Grupp with a $250,000 research grant. The donation will support the ongoing CAR T-cell therapy research of CHOP's immunotherapy program.
The Emily Whitehead Foundation has contributed $250,000 to SU2C's Phillip A. Sharp Innovation in Collaboration Awards. The grant will be split into increments of $125,000 for awards in 2018 and 2019, each supporting further research of pediatric cancer immunotherapy treatments.